Overview

At Cullinan Therapeutics, our mission is to develop potential first- or best-in-class, high-impact therapies for autoimmune diseases and cancer. We identify high-impact targets, which we define as those that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both autoimmune diseases and cancer, and then select what we believe is the optimal therapeutic modality for those targets. Using this strategy, we have built a pipeline of targeted immunology and oncology product candidates that aim to maximize therapeutic potential for patients.